Core Viewpoint - A class action securities lawsuit has been filed against Quantum Computing Inc. (NASDAQ: QUBT) alleging securities fraud that affected investors between March 30, 2020, and January 15, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that defendants overstated the capabilities of Quantum Computing Inc.'s quantum computing technologies, products, and services [2]. - It is alleged that the defendants misrepresented the nature and scope of Quantum Computing Inc.'s relationship with NASA, including contracts and subcontracts [2]. - The complaint asserts that the company exaggerated its progress in developing a thin film lithium niobate (TFLN) foundry and the scale of its purported TFLN foundry and orders for TFLN chips [2]. - The business dealings with Quad M and millionways are claimed to be related party transactions, which were not disclosed [2]. - The lawsuit suggests that Quantum Computing Inc.'s revenues were partially dependent on undisclosed related party transactions, which could significantly harm the company's business and reputation once revealed [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until April 28, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Insights - Quantum BioPharma Ltd. reported strong financial and operational results for Q4 and the full year 2024, highlighting a solid balance sheet and sufficient working capital to sustain operations through January 2027 [2][12]. Financial Performance - Cash and cash equivalents increased to $12.1 million USD as of December 31, 2024, up from $11.1 million USD in 2023 [3]. - Operating expenses were reduced to $16.1 million USD in 2024, a decrease of over 32% from $23.8 million USD in 2023 [3]. - Net cash used in operations improved by 36%, totaling $6.9 million USD in 2024 compared to $10.8 million USD in 2023 [4]. - The net loss for 2024 was $14.9 million USD, an improvement of 18% from $18.2 million USD in 2023 [6]. Research and Development - External research and development fees rose to $6.1 million USD in 2024, up from $3.9 million USD in 2023, due to advancements in key clinical assets [5]. - The company completed a Phase 1 clinical trial for its multiple sclerosis drug, Lucid-21-302, which was deemed safe and well-tolerated [14]. Product Development and Market Strategy - The company initiated the development of rekvry, an alcohol misuse treatment aimed at emergency and hospital settings, addressing an unmet healthcare need [8]. - The clinical trial for unbuzzd demonstrated a significant reduction in blood alcohol concentration, with results showing an average reduction of over 40% faster than control subjects [13]. - Celly Nutrition Corp., the licensee for unbuzzd, is exploring an IPO to raise up to $10 million USD and expand market reach [10][15]. Strategic Initiatives - Quantum BioPharma has engaged in purchasing $3.5 million worth of Bitcoin and other cryptocurrencies to diversify its treasury [16]. - The company is focused on building a multi-channel distribution strategy for unbuzzd, with upcoming launches in collaboration with FUSION Distribution [12][16].

Stocks in the quantum computing sector soared in 2024. One of the leaders was IonQ (IONQ -3.55%) with a massive 237% gain. It's been a different story so far this year though. IonQ shares are down by 43% year to date.But shares are rebounding this week. IonQ stock was up double-digits before paring some of those gains in late trading Thursday. As of that time, shares remained higher for the week by 8.2%, according to data provided by S&P Global Market Intelligence.Nvidia's CEO walks it backMuch of the 2025 ...

Quantum Corporation (QMCO) stock remained resilient amid a volatile market environment, with a 328.9% gain in the past six months against the Zacks Computer- Storage Devices industry's decline of 19.9%. It has also outperformed the Zacks Computer and Technology sector’s decline of 2.5% and the S&P 500 composite’s decrease of 0.5%. QMCO’s hares have risen 27.3% in the past month.Image Source: Zacks Investment ResearchLet’s analyze QMCO’s potential upsides and risks to make an informed portfolio decision.Myri ...

Core Insights - Quantum Computing Inc. (QCi) has appointed Eric Schwartz to its Board of Directors, bringing significant commercial and financial expertise to the company [1][4] - Schwartz has over 20 years of experience in corporate finance, mergers and acquisitions, and corporate strategy, currently serving as Managing Director at Castle Harlan [2][3] - His extensive board experience includes roles at various companies, which will be beneficial for QCi as it aims for long-term growth and market acceptance of its quantum machines [3][4] Company Overview - QCi is an innovative company focused on integrated photonics and quantum optics technology, providing accessible and affordable quantum machines [5] - The company's products are designed to operate at room temperature and low power, targeting high-performance computing, artificial intelligence, cybersecurity, and remote sensing applications [5] Strategic Implications - The appointment of Schwartz is expected to enhance QCi's strategic insights and operational expertise, particularly in commercialization and manufacturing scale-up [4] - Schwartz expressed enthusiasm about joining QCi at a pivotal time, emphasizing the company's strong foundation for growth and its commitment to solving real-world problems [4]

You might be surprised to learn which AI giants are poised to dominate the quantum computing market in the long run. These three familiar companies are building the future in two cutting-edge fields simultaneously.Artificial intelligence (AI) has been a game-changing growth driver for more than two years now. More recently, investors have embraced quantum computing as the Next Big Thing with wealth-building promise.Wouldn't it be nice if you could invest in both of these market-moving tech trends with a sin ...

In 1999, a small graphics chipmaker called Nvidia (NASDAQ: NVDA) went public at $12 per share. Today, that same company stands as the world's most valuable semiconductor giant. A modest $500 investment at Nvidia's IPO would have mushroomed into an astounding $1.61 million today -- a 322,600% return that dwarfs the S&P 500's performance over the same period. The potential for such transformative wealth creation has investors constantly hunting for the next technological revolution. Quantum computing may repr ...

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) and certain officers.  The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-01457, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired QCI securities between March 30, 2020 and January 15, 2025, ...

Core Viewpoint - Scope Technologies Corp. is developing a mobile application that aims to provide quantum-resilient privacy for communication and file sharing, addressing the challenges posed by conventional encryption in a quantum-ready world [1][3]. Group 1: Product Features - The mobile platform will feature full round-trip encryption, ensuring that only the sender and recipient can access messages or files, effectively excluding service providers and third parties from any access [2][5]. - It is designed to withstand current and future cyber threats, including those from quantum computing, reflecting the company's mission to enhance data protection for businesses and privacy-conscious users [3][7]. - The app will be white-label ready, allowing enterprises to deploy the platform under their own brand, integrating secure communications directly into their workflows [6][9]. Group 2: Market Context - There is increasing regulatory pressure on sectors such as government, healthcare, and finance to safeguard digital information, creating a demand for secure, enterprise-grade communication tools [4][8]. - The rise of consumer messaging apps like Telegram, which has surpassed 1 billion users, highlights the need for secure alternatives that prioritize user privacy and compliance [4][8]. Group 3: Strategic Importance - The introduction of Scope's mobile app represents a critical inflection point in the market, as businesses seek scalable solutions that go beyond outdated communication platforms [3][4]. - The app's architecture minimizes metadata exposure, reducing data leakage and enhancing security against cyberattacks [7].

More than 15 years of professional investment experience in global equities across all sectors. My investment style is fundamental, bottom-up, long-term, and quality growth-oriented. I am seeking companies specializing in niche markets, with strong growth potential, a solid management team, a sound capital allocation policy, and, most importantly, reasonable valuation. I do not chase quarterly results, nor do I follow the herd mentality. I do not use short-term stock performance as the measure of a company' ...